K Number
K160355
Device Name
CX20N(CX20PUX)
Manufacturer
Date Cleared
2016-04-07

(59 days)

Product Code
Regulation Number
892.2050
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The CX20N(CX20PUX) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners.

Device Description

CX20N(CX20PUX) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for color image display. The WIDE controller board is installed into the PACS workstation computer system to display PACS medical images.

AI/ML Overview

The provided document describes a 510(k) premarket notification for a medical monitor system, CX20N(CX20PUX). This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device, rather than proving a device's standalone performance against a disease or condition. As such, the information you're requesting regarding AI performance, human reader improvement, and clinical study details related to a specific medical condition is not applicable to this device or its submission.

The device is a TFT LCD Medical Monitor System intended for displaying and viewing digital medical images for review and analysis by trained medical practitioners. It is not an AI-powered diagnostic tool.

Below is the information specifically related to the acceptance criteria and study that proves the device meets them, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The document refers to technical specifications and compliance with international standards for medical electrical equipment. The "acceptance criteria" are implied by adherence to these standards and by demonstrating comparable performance to a predicate device.

ParameterAcceptance Criteria (Implied by Predicate & Standards)Reported Device Performance (CX20N(CX20PUX))
Technical Characteristics:
Resolution1600 × 1200 (Matches predicate)1600 × 1200
Pixel pitch0.270mm × 0.270mm (Matches predicate)0.270mm × 0.270mm
BrightnessComparable to or better than 770cd/m² (Predicate)800cd/m²
Contrast RatioComparable to or better than 1100:1 (Predicate)1400:1
LCD Panel Size21.3" (Matches predicate)21.3"
Input SignalDVI-I (Predicate); additional signals acceptableDVI-I, DisplayPort
Power Supply100~240 VAC, 50/60Hz (Matches predicate)100~240 VAC, 50/60Hz
Color/MonochromeColor (Matches predicate)Color
Safety Standards (Compliance with):
IEC 60601-1General Requirements For Basic Safety And Essential PerformanceComplies
IEC 60601-1-2Electromagnetic Compatibility - Requirements And TestsComplies
Functional Performance (Tests for):Meets specified criteriaMet Acceptance Criteria
ResolutionMet Acceptance Criteria
LuminanceMet Acceptance Criteria
ContrastMet Acceptance Criteria
NoiseMet Acceptance Criteria

2. Sample Size Used for the Test Set and Data Provenance

Not applicable. This device is a medical monitor, not a diagnostic or screening algorithm that processes medical image data. The "test set" in this context refers to the physical device itself undergoing engineering and performance verification tests, not a dataset of patient images.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

Not applicable. As this is a medical display monitor, there is no "ground truth" to be established by medical experts for its performance in diagnosing or detecting conditions. The "ground truth" for this device relates to engineering specifications and performance standards, which are verified through technical measurements performed by qualified testers/engineers.

4. Adjudication Method for the Test Set

Not applicable. The evaluation of the device's adherence to technical specifications and international standards typically involves objective measurements and compliance checks performed by engineers, not a consensus-based adjudication by medical professionals.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No. A MRMC comparative effectiveness study is designed to assess the performance of diagnostic tools (e.g., algorithms or human readers) in interpreting medical images, usually in the context of disease detection or characterization. This device is a display monitor, not a diagnostic tool, so such a study was not performed.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Not applicable. This device is a hardware component (monitor) and does not involve an algorithm for diagnostic or interpretative purposes.

7. The Type of Ground Truth Used

For the technical performance aspects, the "ground truth" is defined by the engineering specifications and established international standards (e.g., IEC 60601-1, IEC 60601-1-2) for medical electrical equipment and displays. Compliance is determined by objective measurements against these predefined standards. For the purpose of 510(k) clearance, the primary "ground truth" for the overall device is its substantial equivalence to the predicate device (K032960) in terms of intended use, technological characteristics, and performance.

8. The Sample Size for the Training Set

Not applicable. This device does not use machine learning or AI algorithms that require a "training set" of data.

9. How the Ground Truth for the Training Set was Established

Not applicable. There is no training set for this device.

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 7, 2016

WIDE Corporation % Mr. YeoJin Yun RA Manager 12 Wongomae-Ro, Giheung-Gu Yongin-Si, Gyeonggi-Do 17086 REPUBLIC OF KOREA

Re: K160355 Trade/Device Name: CX20N(CX20PUX) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: PGY Dated: February 5, 2016 Received: February 8, 2016

Dear Mr. Yun:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Robert Ochs

Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K160355

Device Name CX20N(CX20PUX)

Indications for Use (Describe)

The CX20N(CX20PUX) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary

[As required by 21 CFR 807.92]

This 510(k) summary of safety and effectiveness information is prepared in accordance with 21 CFR 807.92

1. Date Prepared [21 CFR 807.92(a) (1)]

02/05/2016

2. Submitter's Information [21 CFR 807.92(a) (1)]

Name of Sponsor:WIDE Corporation.
Address:12 Wongomae-Ro, Giheung-Gu, Yongin-Si, Gyeonggi-Do17086, Republic of Korea
Contact Name:YeoJin Yun
Telephone #:+82-31-218-1675
Fax #:+82-31-218-7400
Email:yyjin@widecorp.com
Registration Number:3004082357
Name of Manufacturer:Same as Sponsor

3. Trade Name, Common Name, Classification [21 CFR 807.92(a) (2)]

Model Name:CX20N(CX20PUX)
Common Name:TFT LCD Medical Monitor System
Classification Name:Display, Diagnostic Radiology
Regulation Number:21 CFR 892.2050
Product Code:PGY
Device Class:2
Review Panel:Radiology

4. Identification of Predicate Device(s) [21 CFR 807.92(a) (3)]

510(k) Number:K032960
Applicant:WIDE Corporation.
Model Name:The WIDE 2MP TFT LCD Monitor System
Common Name:TFT LCD Medical Monitor System
Classification Name:System, Image Processing, Radiological
Regulation Number:21 CFR 892.2050
Product Code:LLZ
Device Class:2

{4}------------------------------------------------

5. Description of the Device [21 CFR 807.92(a) (4)]

CX20N(CX20PUX) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for color image display. The WIDE controller board is installed into the PACS workstation computer system to display PACS medical images.

6. Intended Use [21 CFR 807.92(a) (5)]

CX20N(CX20PUX) is intended to be used to display and view digital medical images for review and analysis by trained medical practitioners.

7. Technological Characteristics [21 CFR 807.92(a) (6)]

The device is an image display system which consists of computer software and components. The device does not contact the patient, nor does it control any life sustaining devices. A physician or trained medical practitioner provides ample opportunity for competent human intervention to interpret images and information being displayed.

ParameterSubject DevicePredicate Device
510(k) NumberUnknownK032960
Model NameCX20N(CX20PUX)The WIDE 2MP TFT LCDMonitor System
ManufacturerWIDE Corporation.
Common NameTFT LCD Medical Monitor System
Classification NameDisplay, Diagnostic RadiologySystem, Image Processing,Radiological
Classification PanelRadiology
Classification Regulation21 CFR 892.2050
Product CodePGYLLZ
Device ClassClass II
Intended UseCX20N(CX20PUX) is intendedto be used in displaying andviewing digital medical imagesfor review and analysis by trainedmedical practitioners.The WIDE 2MP TFT LCDMonitor System If 7902Adisplaying and viewing digitalmedical images for review andanalysis by trained medicalpractitioners.
LCD Panel Size21.3"21.3"

8. Substantial Equivalence [21 CFR 807.92(b) (1) and 807.92]

{5}------------------------------------------------

ParameterSubject DevicePredicate Device
Resolution1600×12001600×1200
Pixel pitch0.270mm x 0.270mm0.270mm x 0.270mm
Brightness800cd/m²770cd/m²
Contrast Ratio1400 : 11100:1
Input SignalDVI-I, DisplayPortDVI-I
Power Supply100~240 VAC, 50/60Hz100~240 VAC, 50/60Hz
Color/MonochromeColorColor

When compared to the predicate devices (K032960), the CX20N(CX20PUX) presented in this submission has the same of the followings:

  • Intended Use
  • Technological characteristics
  • LCD Panel Size
  • Resolution
  • Pixel pitch

The two devices share the similar performance as the following:

  • Brightness
  • Contrast Ratio

9. Summary of Non-Clinical Data

CX20N(CX20PUX) comply with the following international and FDA-recognized consensus standards:

IEC 60601-1:Medical Electrical Equipment -- Part 1: GeneralRequirements For Basic Safety And Essential Performance
IEC 60601-1-2:Medical Electrical Equipment - Part 1-2: GeneralRequirements For Basic Safety And Essential Performance -Collateral Standard: Electromagnetic Compatibility -Requirements And Tests

The tests conducted for resolution, luminance, contrast and noise all met the acceptance criteria specified in the standards.

10. Summary of Clinical Data

No clinical studies were considered necessary and performed.

{6}------------------------------------------------

11. Conclusion [21 CFR 807.92(b) (3)]

Subject Device is substantially equivalent to the currently marketed and predicate devices in terms of design features, fundamental scientific technology, indications for use, and safety and effectiveness.

Additionally, the safety of the subject device was validated through tests including IEC60601-1 and IEC 60601-1-2. The effectiveness of the device was validated through tests for resolution, luminance, contrast and noise.

The results of these tests demonstrate that CX20N(CX20PUX) meets the acceptance criteria and is adequate for this intended use. The comparison of technological characteristics, non-clinical performance data, safety testing demonstrates that the device is as safe and effective as the predicate device and performs as well as the predicate device.

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).